financetom
Business
financetom
/
Business
/
Amazon Insider Sold Shares Worth $1,000,098, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amazon Insider Sold Shares Worth $1,000,098, According to a Recent SEC Filing
Dec 6, 2024 2:13 PM

04:57 PM EST, 12/06/2024 (MT Newswires) -- Jonathan Rubinstein, Director, on December 04, 2024, sold 4,549 shares in Amazon ( AMZN ) for $1,000,098. Following the Form 4 filing with the SEC, Rubinstein has control over a total of 92,554 shares of the company, with 92,554 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1018724/000101872424000200/xslF345X05/wk-form4_1733522032.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rupert Resources Q4 Loss Narrows on Cost Cuts and Decline in Impairments
Rupert Resources Q4 Loss Narrows on Cost Cuts and Decline in Impairments
May 29, 2024
08:31 AM EDT, 05/29/2024 (MT Newswires) -- Rupert Resources ( RUPRF ) , which rose 1.8% yesterday, said on Wednesday that its fourth-quarter loss narrowed amid a decrease in general and administrative costs, a decline in impairment of exploration and evaluation assets, and a decrease in share-based payments. The company reported a fourth-quarter total comprehensive loss attributable to owners of...
Heron Therapeutics Submits Prior Approval Supplement to the FDA for Zynrelef Vial Access Needle
Heron Therapeutics Submits Prior Approval Supplement to the FDA for Zynrelef Vial Access Needle
May 29, 2024
08:35 AM EDT, 05/29/2024 (MT Newswires) -- Heron Therapeutics ( HRTX ) said Wednesday it submitted the prior approval supplement to the US Food and Drug Administration for Zynrelef's extended-release solution Vial Access Needle. The company is seeking approval for the new Zynrelef kit, which could simplify preparation and reduce the drug's withdrawal time to 20 to 45 seconds from...
Red Pine Says Wawa Project Drilling Shows Gold Mineralization as it Deals With Misreported Prior Assay Results
Red Pine Says Wawa Project Drilling Shows Gold Mineralization as it Deals With Misreported Prior Assay Results
May 29, 2024
08:37 AM EDT, 05/29/2024 (MT Newswires) -- Red Pine Exploration ( RDEXF ) on Wednesday said exploration drilling at its Wawa gold project in Ontario showed gold mineralization, announcing results that come after the company had to correct earlier assay results from the project. The company said best results from from assays on 14 exploration holes drilled into the Jubilee...
PMV Pharmaceuticals, Foundation Medicine to Develop Companion Diagnostic for Rezatapopt
PMV Pharmaceuticals, Foundation Medicine to Develop Companion Diagnostic for Rezatapopt
May 29, 2024
08:39 AM EDT, 05/29/2024 (MT Newswires) -- PMV Pharmaceuticals ( PMVP ) and Foundation Medicine said Wednesday they are collaborating to develop Foundation Medicine's FoundationOneCDx tissue-based genomic profiling test as a companion diagnostic for PMV's rezatapopt investigational therapy. Rezatapopt is being evaluated as a potential treatment for locally advanced or metastatic solid tumors with a TP53 Y220C mutation while FoundationOneCDx...
Copyright 2023-2026 - www.financetom.com All Rights Reserved